Sign in
Enrolling by invitationNo phase

Testing AI speech analysis to help detect mental health conditions

Tests whether AI analysis of speech can help assess several mental health conditions.

Key facts

Who runs it
Psyrin Inc.
Where
Brookline and Zanesville, United StatesSee the 2 sites
Trial code
Registry title
Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
Status
Enrolling by invitation
People taking part
500 people, planned
Started
4 Feb 2025
Planned end
Jul 2026
Type of study
Observational, 2 groups
Treatments tested
  • Solicue Machine Learning Models
  • Mercuria Machine Learning Models
Record updated
3 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 16 to 60 who are being assessed or referred for a mental or behavioral health condition. They do speech tasks on a device at home.

Age
16 to 60 years (the registry header lists 13 to 60 years)
Sex
All sexes can join.
Disease stage
People currently being assessed, or referred for assessment, for a mental or behavioral health condition such as ADHD, autism, bipolar disorder, generalized anxiety, major depression, OCD, PTSD or schizophrenia spectrum disorders.

Main reasons for not taking part

  • Acute mental health crisis or severe symptoms that stop meaningful taking part, including acute intoxication
  • Severe cognitive impairment or intellectual disability that stops understanding the study or doing the speech tasks
  • Not fluent in English
  • No device with a microphone or no stable internet connection

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Participants aged between 16 and 60 years
  • Individuals currently undergoing or referred for clinical assessment of mental or behavioral health conditions (including but not limited to ADHD, ASD, BPAD, GAD, MDD, OCD, PTSD, SSD)
  • Fluent in English
  • Capable of providing informed consent, or in the case of minors, having a parent or legal guardian who can provide consent on their behalf
  • Access to a device (smartphone, tablet, or computer) with a microphone and stable internet connectivity, necessary for completing the speech tasks

Who cannot take part

  • Severe cognitive impairment or intellectual disability that would prevent understanding of the study procedures or completion of the speech tasks
  • Individuals experiencing acute mental health crises or severe symptoms that would preclude meaningful participation in the study, including acute intoxication
  • Lack of fluency in English
  • Technical limitations: Inability to access a suitable device or internet connection for completing the speech tasks

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 13 and 60 years old?

Where in United States

  • The Brookline CenterBrookline, United StatesEnrolling by invitation
  • Allwell Behavioral Health ServicesZanesville, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This study investigates whether AI-driven analysis of speech can accurately predict clinical diagnoses and assess risk for various mental or behavioral health conditions, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, generalized anxiety disorder, major depressive disorder, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and schizophrenia. We aim to develop tools that can support clinicians in making more accurate and efficient diagnoses.

The 2 groups in the trial

  • Solicue (Any Mental Health Disorder)

    Any participant enrolled in the study and not part of additional analysis group.

    Treatment: Solicue Machine Learning Models

  • Solicue & Mercuria (Bipolar Disorder & Major Depressive Disorder)

    Any participant enrolled in the study and exhibiting depressive symptoms as measured by PHQ-9 score.

    Treatment: Solicue Machine Learning Models and Mercuria Machine Learning Models

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models: Testing Speech-Based Machine Learning Algorithms for Clinical Assessment and Risk Stratification in Mental Health Presentations
Plain-language title
Testing AI speech analysis to help detect mental health conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06792175, who can take part
Record updated
3 September 2025